Shares of Amryt Pharma plc (LON:AMYT – Get Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 143 ($1.85) and traded as low as GBX 143 ($1.85). Amryt Pharma shares last traded at GBX 143 ($1.85), with a volume of 90,726 shares trading hands.
Amryt Pharma Trading Down 11.7 %
The company has a market cap of £457.11 million and a price-to-earnings ratio of -4.33. The firm has a 50 day moving average price of GBX 143 and a two-hundred day moving average price of GBX 143. The company has a quick ratio of 1.14, a current ratio of 1.80 and a debt-to-equity ratio of 66.05.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
See Also
- Five stocks we like better than Amryt Pharma
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Why Call Options Volume for These 2 Stocks Spiked Together
- How is Compound Interest Calculated?
- MarketBeat Week in Review – 7/22 – 7/26
- Profitably Trade Stocks at 52-Week Highs
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
